Literature DB >> 675585

Studies on the binding of heparin to prothrombin and thrombin and the effect of heparin-binding on thrombin activity.

B Nordenman, I Björk.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 675585     DOI: 10.1016/0049-3848(78)90269-4

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  8 in total

1.  A novel one-step purification of human alpha-thrombin after direct activation of crude prothrombin enriched from plasma.

Authors:  P K Ngai; J Y Chang
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

2.  Properties of antithrombin-thrombin complex formed in the presence and in the absence of heparin.

Authors:  A Danielsson; I Björk
Journal:  Biochem J       Date:  1983-08-01       Impact factor: 3.857

Review 3.  Mechanism of the anticoagulant action of heparin.

Authors:  I Björk; U Lindahl
Journal:  Mol Cell Biochem       Date:  1982-10-29       Impact factor: 3.396

4.  Binding to antithrombin of heparin fractions with different molecular weights.

Authors:  A Danielsson; I Björk
Journal:  Biochem J       Date:  1981-02-01       Impact factor: 3.857

5.  Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipid syndrome.

Authors:  R Weiss; A Bitton; L Nahary; M T Arango; I Benhar; M Blank; Y Shoenfeld; J Chapman
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

6.  Electrostatic interactions in the heparin-enhanced reaction between human thrombin and antithrombin.

Authors:  L C Petersen; M Jørgensen
Journal:  Biochem J       Date:  1983-04-01       Impact factor: 3.857

7.  Heterogeneity of rat skin heparin chains with high affinity for antithrombin.

Authors:  A A Horner
Journal:  Biochem J       Date:  1987-06-15       Impact factor: 3.857

8.  Effect of dextran sulphates on thrombin activity.

Authors:  K Suzuki; S Hashimoto
Journal:  J Clin Pathol       Date:  1979-05       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.